When available, the Online Course format is included with the hard copy, eBook, or audio book formats!
Review Date: January 25, 2017
Expiration Date: January 24, 2020
Original Release Date: July 31, 2013
Hypertension affects approximately one third of all adults in the United States. Understanding the types, effects, and treatments of hypertension is essential to anticipating how hypertension may affect the dental patient. Many patients may experience an elevation in blood pressure at the time of their visit as the result of fear and anxiety related to dental treatment. In addition, certain pharmacologic therapies for hypertension have side effects of oral significance.
This basic-level course familiarizes dental professionals with hypertension, its types, and its impact on general wellness. The course reviews the pathophysiology of hypertension and describes nonpharmacologic options for the treatment of hypertension, including lifestyle and dietary modifications, as well as pharmacologic approaches. A firm understanding of this prevalent disease and its implications for treatment in the dental office will help all dental professionals provide the highest quality of care to their dental patients.
AGD Subject Code: 750
Western Schools designates this activity for 3 continuing education credits.
- Describe hypertension and its impact on general health.
- Identify essential and secondary hypertension and hypertensive crisis.
- Describe the pathophysiology of essential hypertension.
- Describe lifestyle and dietary modifications as nonpharmacologic treatment options for hypertension.
- List the advantages and disadvantages of current drug classes in pharmacologic treatment of hypertension.
- Describe the dental management of hypertensive patients.
David A. Verhaag, MD, maintained a private practice as a family physician in Roseville, California, for more than 30 years. He received his bachelor of arts degree from the University of California, Santa Barbara, and his medical training at the School of Medicine at the University of California, Los Angeles (UCLA). Dr. Verhaag completed his internship at UCLA Harbor General Hospital and his residency at the UC Davis Medical Center (formerly known as the Sacramento Medical Center) in family practice. He was founder and partner in the Oakridge Medical Group in Roseville, California, where he practiced for 17 years. Dr. Verhaag was an active staff member of the Sutter Roseville Medical Center clinical faculty, member of the UC Davis Department of Family Practice, and member of the Quality Review Committee of the Medical Board of California. Dr. Verhaag co-published the article “Prescribing for Chronic Pain” in the Journal of Psychoactive Drugs.
- Courses must be completed on or before the expiration date noted in the course description above.
- You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
- Through our review processes, Western Schools ensures that the course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools’ policy not to accept commercial support.
- All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.
- There are no prerequisites for this course.